TORONTO, Sept. 12, 2017 /CNW/ - Cronos Group Inc. (TSXV:
MJN) (OTC: PRMCF) ("Cronos" or the "Company") is pleased to
announce that it is the first cannabis company to be admitted into
the Nasdaq International Designation program under the symbol OTC –
Nasdaq International Designation: PRMCF. This is an
over-the-counter (OTC) platform designed for non-U.S.
companies. The program provides member companies with
Nasdaq's visibility offering, allowing for greater access to
U.S.-based investors.
"We've always had a strong U.S. investor base and that investor
base continues to grow. This designation will improve Cronos'
visibility across U.S. capital markets and increase shareholder
confidence and liquidity," said Mike
Gorenstein, CEO of Cronos.
Member companies of the Nasdaq International Designation are not
listed or traded on The Nasdaq Stock Market, LLC. and are not
subject to the same listing or qualification standards applicable
to securities listed or traded on an exchange. The Company's
Nasdaq International Designation profile page can be found on
http://business.nasdaq.com/list/International-Designation/cronos-group.html
About Cronos Group
Cronos Group is a geographically diversified and vertically
integrated cannabis company that operates two wholly-owned Licensed
Producers ("LPs") regulated within Health Canada's Access to
Cannabis for Medical Purposes Regulations (the "ACMPR") and holds a
portfolio of minority investments in other Licensed Producers. The
Company's flagship LPs, Peace Naturals Project Inc. (Ontario) and In The Zone Produce Ltd.
(British Columbia), are
collectively situated on over 125 acres of agricultural, licensed
land. Cronos Group is focused on building an international iconic
brand portfolio, providing patients with compassionate and
personalized care, and creating value for our shareholders.
Forward-looking statements
This news release may contain "forward-looking information" and
"forward-looking statements" within the meaning of applicable
Canadian securities legislation. All information contained herein
that is not clearly historical in nature may constitute
forward-looking information. Forward-looking statements are
necessarily based upon a number of estimates and assumptions that,
while considered reasonable by management, are inherently subject
to significant business, economic and competitive risks,
uncertainties and contingencies that may cause actual financial
results, performance or achievements to be materially different
from the estimated future results, performance or achievements
expressed or implied by those forward-looking statements and the
forward-looking statements are not guarantees of future
performance. Except as required by law, Cronos Group disclaims any
obligation to update or revise any forward-looking statements.
Readers are cautioned not to put undue reliance on these
forward-looking statements. This news release contains information
obtained by Cronos Group from third parties. Cronos Group believes
such information to be accurate but has not independently verified
such information.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
For more information, please visit www.thecronosgroup.com.
SOURCE Cronos Group Inc.